Cite

HARVARD Citation

    Mollnes, T. et al. (2022). Application of the C3 inhibitor compstatin in a human whole blood model designed for complement research – 20 years of experience and future perspectives. Seminars in immunology. p. . [Online]. 
  
Back to record